Joel Beatty
Stock Analyst at Baird
(4.60)
# 217
Out of 5,241 analysts
215
Total ratings
52.33%
Success rate
34.45%
Average return
Main Sectors:
Stocks Rated by Joel Beatty
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintains: Outperform | $45 → $48 | $37.48 | +28.07% | 4 | May 13, 2026 | |
| AXSM Axsome Therapeutics | Maintains: Outperform | $241 → $246 | $227.72 | +8.03% | 6 | May 5, 2026 | |
| ELF e.l.f. Beauty | Maintains: Outperform | $115 → $90 | $56.43 | +59.49% | 10 | Apr 28, 2026 | |
| DNLI Denali Therapeutics | Maintains: Outperform | $32 → $34 | $18.62 | +82.60% | 4 | Apr 7, 2026 | |
| IMMP Immutep | Downgrades: Neutral | $7 → $1 | $0.52 | +92.42% | 6 | Mar 13, 2026 | |
| DNTH Dianthus Therapeutics | Maintains: Outperform | $67 → $132 | $86.16 | +53.20% | 4 | Mar 10, 2026 | |
| CTNM Contineum Therapeutics | Maintains: Outperform | $14 → $20 | $13.72 | +45.77% | 4 | Mar 6, 2026 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $275 → $433 | $342.58 | +26.39% | 3 | Feb 20, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Outperform | $72 → $47 | $25.00 | +88.00% | 5 | Dec 30, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Outperform | $160 → $209 | $228.77 | -8.64% | 5 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $19 | $13.29 | +43.02% | 5 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $10 → $7 | $3.58 | +95.53% | 3 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $6 | $2.62 | +129.01% | 5 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $9 | $32.68 | -72.46% | 6 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $31 | $21.40 | +44.86% | 4 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $38 → $24 | $29.82 | -19.52% | 5 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $680 | $799.32 | -14.93% | 7 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $66 | $71.47 | -7.65% | 15 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $32 | $31.18 | +2.63% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $75 | $77.47 | -3.19% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $65 | $51.81 | +25.46% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $540 → $240 | $0.19 | +129,210.34% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $4.5 | $1.29 | +248.84% | 2 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $25 | $15.86 | +57.68% | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $28 | $20.23 | +38.41% | 2 | Oct 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $1.55 | +932.26% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4 → $1.25 | $1.36 | -8.09% | 2 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $44 | $1.15 | +3,726.09% | 3 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $60 → $58 | $76.67 | -24.35% | 6 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $24 | $28.21 | -14.92% | 2 | Nov 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $18 | $7.47 | +140.96% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $9 → $6 | $1.67 | +259.28% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $36 → $28 | $8.79 | +218.54% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $170 → $175 | $286.98 | -39.02% | 2 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 | $6.28 | +122.93% | 8 | Jan 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $108 | $17.55 | +515.38% | 10 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $78 | $74.23 | +5.08% | 3 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $140 → $100 | $19.65 | +408.91% | 2 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $120 | $14.51 | +727.30% | 14 | Apr 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $480 → $450 | $3.94 | +11,321.32% | 2 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.12 | - | 12 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $15 | $9.06 | +65.56% | 11 | Sep 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $14 → $11 | $21.71 | -51.64% | 8 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $19 | $9.22 | +106.07% | 3 | Nov 10, 2017 |
Alkermes
May 13, 2026
Maintains: Outperform
Price Target: $45 → $48
Current: $37.48
Upside: +28.07%
Axsome Therapeutics
May 5, 2026
Maintains: Outperform
Price Target: $241 → $246
Current: $227.72
Upside: +8.03%
e.l.f. Beauty
Apr 28, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $56.43
Upside: +59.49%
Denali Therapeutics
Apr 7, 2026
Maintains: Outperform
Price Target: $32 → $34
Current: $18.62
Upside: +82.60%
Immutep
Mar 13, 2026
Downgrades: Neutral
Price Target: $7 → $1
Current: $0.52
Upside: +92.42%
Dianthus Therapeutics
Mar 10, 2026
Maintains: Outperform
Price Target: $67 → $132
Current: $86.16
Upside: +53.20%
Contineum Therapeutics
Mar 6, 2026
Maintains: Outperform
Price Target: $14 → $20
Current: $13.72
Upside: +45.77%
Praxis Precision Medicines
Feb 20, 2026
Maintains: Outperform
Price Target: $275 → $433
Current: $342.58
Upside: +26.39%
Ultragenyx Pharmaceutical
Dec 30, 2025
Maintains: Outperform
Price Target: $72 → $47
Current: $25.00
Upside: +88.00%
Jazz Pharmaceuticals
Nov 18, 2025
Maintains: Outperform
Price Target: $160 → $209
Current: $228.77
Upside: -8.64%
Oct 16, 2025
Maintains: Outperform
Price Target: $10 → $19
Current: $13.29
Upside: +43.02%
Sep 30, 2025
Maintains: Outperform
Price Target: $10 → $7
Current: $3.58
Upside: +95.53%
Aug 13, 2025
Maintains: Outperform
Price Target: $4 → $6
Current: $2.62
Upside: +129.01%
Jul 8, 2025
Maintains: Neutral
Price Target: $7 → $9
Current: $32.68
Upside: -72.46%
May 19, 2025
Maintains: Outperform
Price Target: $28 → $31
Current: $21.40
Upside: +44.86%
May 16, 2025
Downgrades: Neutral
Price Target: $38 → $24
Current: $29.82
Upside: -19.52%
May 13, 2025
Upgrades: Outperform
Price Target: $680
Current: $799.32
Upside: -14.93%
May 7, 2025
Maintains: Outperform
Price Target: $70 → $66
Current: $71.47
Upside: -7.65%
Mar 3, 2025
Maintains: Outperform
Price Target: $28 → $32
Current: $31.18
Upside: +2.63%
Nov 25, 2024
Initiates: Outperform
Price Target: $75
Current: $77.47
Upside: -3.19%
Oct 30, 2024
Maintains: Neutral
Price Target: $72 → $65
Current: $51.81
Upside: +25.46%
May 15, 2024
Maintains: Outperform
Price Target: $540 → $240
Current: $0.19
Upside: +129,210.34%
Apr 30, 2024
Downgrades: Neutral
Price Target: $4.5
Current: $1.29
Upside: +248.84%
Apr 11, 2024
Maintains: Outperform
Price Target: $24 → $25
Current: $15.86
Upside: +57.68%
Oct 3, 2023
Maintains: Outperform
Price Target: $32 → $28
Current: $20.23
Upside: +38.41%
Jun 1, 2023
Initiates: Outperform
Price Target: $16
Current: $1.55
Upside: +932.26%
May 2, 2023
Maintains: Outperform
Price Target: $4 → $1.25
Current: $1.36
Upside: -8.09%
Apr 13, 2023
Initiates: Outperform
Price Target: $44
Current: $1.15
Upside: +3,726.09%
Feb 7, 2023
Maintains: Outperform
Price Target: $60 → $58
Current: $76.67
Upside: -24.35%
Nov 18, 2022
Maintains: Outperform
Price Target: $18 → $24
Current: $28.21
Upside: -14.92%
Nov 10, 2022
Downgrades: Underperform
Price Target: $18
Current: $7.47
Upside: +140.96%
Aug 29, 2022
Maintains: Outperform
Price Target: $9 → $6
Current: $1.67
Upside: +259.28%
Mar 3, 2022
Upgrades: Neutral
Price Target: $36 → $28
Current: $8.79
Upside: +218.54%
Feb 12, 2021
Downgrades: Neutral
Price Target: $170 → $175
Current: $286.98
Upside: -39.02%
Jan 14, 2021
Downgrades: Neutral
Price Target: $14
Current: $6.28
Upside: +122.93%
Jan 12, 2021
Downgrades: Neutral
Price Target: $108
Current: $17.55
Upside: +515.38%
Aug 10, 2020
Maintains: Buy
Price Target: $80 → $78
Current: $74.23
Upside: +5.08%
Apr 6, 2020
Maintains: Buy
Price Target: $140 → $100
Current: $19.65
Upside: +408.91%
Apr 1, 2020
Maintains: Buy
Price Target: $480 → $120
Current: $14.51
Upside: +727.30%
Mar 26, 2020
Maintains: Buy
Price Target: $480 → $450
Current: $3.94
Upside: +11,321.32%
Mar 17, 2020
Upgrades: Buy
Price Target: n/a
Current: $3.12
Upside: -
Sep 24, 2019
Maintains: Buy
Price Target: $19 → $15
Current: $9.06
Upside: +65.56%
Aug 17, 2018
Upgrades: Neutral
Price Target: $14 → $11
Current: $21.71
Upside: -51.64%
Nov 10, 2017
Maintains: Buy
Price Target: $15 → $19
Current: $9.22
Upside: +106.07%